|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q3 FY2022
As of Jan 31, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
Q1 FY2022
As of Jul 31, 2021
|
Q4 FY2021
As of Apr 30, 2021
|
Q3 FY2021
As of Jan 31, 2021
|
Q2 FY2021
As of Oct 31, 2020
|
Q4 FY2020
As of Apr 30, 2020
|
Q3 FY2020
As of Jan 31, 2020
|
Q2 FY2020
As of Oct 31, 2019
|
Q1 FY2020
As of Jul 31, 2019
|
Q4 FY2019
As of Apr 30, 2019
|
Q3 FY2019
As of Jan 31, 2019
|
Q2 FY2019
As of Oct 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Right-of-use operating lease asset | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Oil and natural gas properties, net based on the full cost method of accounting | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related party | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Convertible preferred Series B stock liability | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-current portion of operating lease liability | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Temporary Equity | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series C Accrued Dividends | ||||||||||||||||||||
| Total Temporary Equity | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Series A Preferred Stock designated: 500,000 shares, par value of $0.001 per share issued and outstanding: 500,000 shares | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Total series A Preferred Stock designated: 500,000 shares, par value of $0.001 per share issued and outstanding: 500,000 shares | ||||||||||||||||||||
| Series C preferred stock issuable | ||||||||||||||||||||
| Series C accrued dividends | ||||||||||||||||||||
| Common stock – 5,000,000,000 common shares, par value of $0.001 per share issued and outstanding: 1,931,932,723 and 1,543,077,167 common shares, respectively | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
